Literature DB >> 24825756

Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 months.

Filis Kazazi-Hyseni1, Mariana Landin, Audrey Lathuile, Gert J Veldhuis, Sima Rahimian, Wim E Hennink, Robbert Jan Kok, Cornelus F van Nostrum.   

Abstract

PURPOSE: The aim of this study was the development of poly(D,L-lactide-co-glycolide) (PLGA) microspheres with controlled porosity, to obtain microspheres that afford continuous release of a macromolecular model compound (blue dextran).
METHODS: PLGA microspheres with a size of around 40 μm and narrow size distribution (span value of 0.3) were prepared with a double emulsion membrane emulsification method. Gene expression programming (GEP) analysis was applied to design and formulate a batch of microspheres with controlled porosity that shows continuous release of blue dextran.
RESULTS: Low porous microspheres with a high loading efficiency were formed at high polymer concentrations (30% w/w in the oil phase) and were characterized with a burst release <10% and a three-phasic release profile of blue dextran. Increasing porosity (10% w/w polymer concentrations), a sustained release of blue dextran was obtained albeit with up to 40% of burst release. The desired formulation, calculated by GEP, resulted in microspheres with 72% loading efficiency and intermediate porosity. Blue dextran was indeed released continuously in almost a zero order manner over a period of 3 months after an initial small burst release of 9%.
CONCLUSIONS: By fine-tuning the porosity, the release profile of PLGA microspheres for macromolecules can be predicted and changed from a three-phasic to a continuous release.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24825756     DOI: 10.1007/s11095-014-1381-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  41 in total

Review 1.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation.

Authors:  J K Armstrong; R B Wenby; H J Meiselman; T C Fisher
Journal:  Biophys J       Date:  2004-09-10       Impact factor: 4.033

Review 3.  Recent developments in manufacturing emulsions and particulate products using membranes.

Authors:  Goran T Vladisavljević; Richard A Williams
Journal:  Adv Colloid Interface Sci       Date:  2004-12-08       Impact factor: 12.984

4.  Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins.

Authors:  Jichao Kang; Steven P Schwendeman
Journal:  Mol Pharm       Date:  2007 Jan-Feb       Impact factor: 4.939

5.  Issues in long-term protein delivery using biodegradable microparticles.

Authors:  Mingli Ye; Sungwon Kim; Kinam Park
Journal:  J Control Release       Date:  2010-05-19       Impact factor: 9.776

6.  Preparation of uniform-sized PLA microcapsules by combining Shirasu porous glass membrane emulsification technique and multiple emulsion-solvent evaporation method.

Authors:  Rong Liu; Guanghui Ma; Fan-Tao Meng; Zhi-Guo Su
Journal:  J Control Release       Date:  2004-12-21       Impact factor: 9.776

Review 7.  Mechanisms of polymer degradation and erosion.

Authors:  A Göpferich
Journal:  Biomaterials       Date:  1996-01       Impact factor: 12.479

Review 8.  The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review.

Authors:  Susanne Fredenberg; Marie Wahlgren; Mats Reslow; Anders Axelsson
Journal:  Int J Pharm       Date:  2011-05-27       Impact factor: 5.875

9.  The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent.

Authors:  M P Desai; V Labhasetwar; E Walter; R J Levy; G L Amidon
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

10.  Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa: a first in vivo study in human patients.

Authors:  Carsten Schmidt; Christian Lautenschlaeger; Eva-Maria Collnot; Michael Schumann; Christian Bojarski; Jörg-Dieter Schulzke; Claus-Michael Lehr; Andreas Stallmach
Journal:  J Control Release       Date:  2012-11-02       Impact factor: 9.776

View more
  4 in total

1.  Finding key nanoprecipitation variables for achieving uniform polymeric nanoparticles using neurofuzzy logic technology.

Authors:  Miguel O Jara; Johanna Catalan-Figueroa; Mariana Landin; Javier O Morales
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

2.  Tailor-made oligonucleotide-loaded lipid-polymer nanosystems designed for bone gene therapy.

Authors:  Patricia García-García; Erik Briffault; Mariana Landin; Carmen Evora; Patricia Diaz-Rodriguez; Araceli Delgado
Journal:  Drug Deliv Transl Res       Date:  2021-02-24       Impact factor: 4.617

3.  Uniform-sized insulin-loaded PLGA microspheres for improved early-stage peri-implant bone regeneration.

Authors:  Xing Wang; Feng Qi; Helin Xing; Xiaoxuan Zhang; Chunxiang Lu; Jiajia Zheng; Xiuyun Ren
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

Review 4.  Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review.

Authors:  Yabing Hua; Yuhuai Su; Hui Zhang; Nan Liu; Zengming Wang; Xiang Gao; Jing Gao; Aiping Zheng
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.